Tag Archives: University of British Columbia

Huntington’s Disease: a Blood Test “Speedometer”? (BBC News / Lancet Neurology)

Posted on June 12, 2017 by Dementia and Elderly Care News

Summary Early research shows promise that a protein biomarker in the blood, called neurofilament light chain (NFL), which is released from damaged brain cells in Huntington’s Disease, may be the basis for a blood test able to predict whether people … Continue reading →

Posted in BBC News, Diagnosis, For Researchers (mostly), In the News, International, Quick Insights, UK, Universal Interest | Tagged BBC Health News, Biomarker Development, Biomarkers, Biomarkers Research Programmes, Blood Tests, Blood-Based Biomarkers, Blood-Based Biomarkers of Pre-Symptomatic Huntington’s Disease, Blood-Based NfL, Canada, Carver College of Medicine: University of Iowa, Cath Stanley: Chief Executive of Hungtington's Disease Association, Centre for Molecular Medicine and Therapeutics: University of British Columbia, CHDI Foundation, Department of Neurology: Leiden University, Department of Psychiatry and Neurochemistry: Sahlgrenska Academy; University of Gothenburg, Department of Psychiatry: University of Iowa, European Research Council, France, Genetics Department: Pitié-Salpêtrière University Hospital, HTT, HTT Mutation Carriers, Huntington Disease, Huntington's Disease Centre: UCL Institute of Neurology, Huntington’s Disease, INSERM, Institut du Cerveau et de la Moelle épinière (ICM), Institute of Neuroscience and Physiology: Sahlgrenska Academy (University of Gothenburg), Institute of Neuroscience and Physiology: Sahlgrenska Academy at University of Gothenburg, Knut and Alice Wallenberg Foundation, Lancet Neurology, Leiden University, Leonard Wolfson Experimental Neurology Centre: University College London, Medical Research Council (MRC), Mutant Huntingtin (mHTT), National Hospital for Neurology and Neurosurgery, National Institute for Health Research UCL Hospitals Biomedical Research Centre, Netherlands, Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurofilament Light Chain (NFL), Neurofilament Light Protein (NF-L), Neurofilament Light Protein in Blood: Potential Biomarker of Huntington's Disease, Neurofilament Light Protein in Blood: Potential Biomarker of Neurodegeneration, Non-Invasive Biomarkers, Pitié-Salpêtrière University Hospital (Paris), Plasma Biomarkers, Plasma Neurofilament Light Chain, Preclinical Biomarkers in Huntington's Disease, Protein-Based Biomarkers in Blood May Deliver Accurate Diagnoses, Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital (Sweden), Serum Neurofilament Light Chain Protein, Sorbonne Universités, Surrogate Biomarkers of Neurodegeneration, Sweden; Clinical Neurochemistry Laboratory: Sahlgrenska University Hospital, Swedish Research Council, Torsten Söderberg Foundation, Transforming Research and Clinical Knowledge in Huntington's Disease (TRACK-HD), UCL Institute of Neurology, University College London (UCL), University of British Columbia, University of Gothenburg, University of Iowa, UPMC University Paris 06: INSERM | Leave a comment

Potential Relationship Between Vitamin A Deficiency and Alzheimer’s Disease Risk? (NHS Choices / Acta Neuropathologica)

Posted on February 5, 2017 by Dementia and Elderly Care News

Summary NHS Choices’ Behind the Headlines covers Chinese and Canadian research, based on both humans and animals, indicating potential associations between Vitamin A deficiency and later development of Alzheimer’s Disease. “ …vitamin A deficiency is a problem in the developing … Continue reading →

Posted in Animal Studies, For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Nutrition, Quick Insights, Universal Interest | Tagged Acta Neuropathologica, Aβ-Plaques, Alzheimer's Disease Pathogenesis, Amyloid Beta, Amyloid Precursor Protein (APP), Amyloid-β (Aβ), Amyloid-β Protein, Behind the Headlines, Beta-Amyloid Plaques, Beta-Site Amyloid-Beta Precursor Protein-Cleaving Enzyme 1 (BACE1), Canada, Canadian Institutes of Health Research (CIHR), Children's Hospital of Chongqing Medical University, Children's Nutrition Research Center, China, China International Science and Technology Cooperation Base for Child Development and Critical Disorders, Chongqing, Chongqing Key Laboratory of Translational Medical Research in Cognitive Development and Learning and Memory Disorders, Critical Appraisals, Department of Psychiatry: University of British Columbia, Genetically Engineered Mice, Marginal Vitamin A Deficiency (MVAD), Mice, Ministry of Education Key Laboratory of Child Development and Disorders, National Natural Science Foundation of China, Townsend Family Laboratories: University of British Columbia, University of British Columbia, Vitamin A, Vitamin A Deficiency, Vitamin A Supplementation, Vitamin Supplements, Vitamins | Leave a comment

International Variations in Cancer Referrals and Cancer Survival (BBC News / BMJ Open)

Posted on May 29, 2015 by Dementia and Elderly Care News

Summary An international survey of 2795 GPs across six countries indicates that patients with possible cancer in the UK are less likely to be referred immediately for tests or to specialists, compared with comparable countries. UK cancer survival rates are … Continue reading →

Posted in BBC News, Charitable Bodies, Commissioning, Community Care, For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Integrated Care, NHS, Northern Ireland, Quick Insights, Standards, Statistics, UK, Universal Interest, Wales | Tagged Aarhus University, Access to Diagnostics and Secondary Care Advice, Australia, Bangor University, BBC Health News, Belfast, BMJ Open, British Columbia, British Columbia (Canada), Canada, Cancer Care Ontario, Cancer Research UK, Cancer Research UK (CRUK), Cancer Treatment Standards, Cancer Waiting Times, Centre for Public Health: Queen's University Belfast, Denmark, Department of Cancer Epidemiology: University of Sydney, Department of Cancer Research and Molecular Medicine: Norwegian University of Science and Technology (NTNU), Department of Clinical Sciences: Kronoberg County Research Council, Department of Family and Community Medicine: University of Toronto, Department of Family Medicine: University of Manitoba, Department of Family Practice: University of British Columbia, Department of General Practice (Australia), Department of Prevention and Cancer Control (Ontario), Department of Primary Health Care Sciences: University of Oxford, Department of Public Health: Aarhus University, Dr Richard Roope: RCGP, Durham University, England, ICBP Module 3 Working Group, Increasing Cancer Mortality and Longer Diagnostic Intervals, International Cancer Benchmarking Partnership (ICBP), International Variations in Cancer Referrals, International Variations in Cancer Survival, Knowledge Translation Research Network Health Services Research Program (Ontario), Kronoberg County Research Council, Manitoba (Canada), New South Wales, New South Wales (Australia), North Wales Centre for Primary Care Research: Bangor University, Northern Ireland, Norway, Norwegian University of Science and Technology (NTNU), Ontario (Canada), Ontario Institute for Cancer Research, Primary Care Diagnostics: University of Exeter Medical School, Primary Health Care Research Evaluation and Development (Australia), Queen's University Belfast, Research Unit for General Practice: Aarhus University, School of Medicine and Health: Wolfson Research Institute, School of Medicine: Queen's University Belfast, School of Public Health: University of Sydney, Speed of Cancer Diagnosis, Sweden, University of British Columbia, University of Exeter Medical School, University of Manitoba, University of Oxford, University of Sydney, University of Toronto, Victoria (Australia), Wales, Wolfson Research Institute, Wolfson Research Institute: Durham University | Leave a comment

Primary Age Related Tauopathy (PART): A New Type / Cause of Cognitive Impairment?

Posted on November 18, 2014 by Dementia and Elderly Care News

Summary The authors of this article propose the introduction of a new term to describe a pathology found to be commonly present in the brains of aged persons; namely “Primary Age-Related Tauopathy (PART). Autopsy studies indicate brains with neurofibrillary tangles … Continue reading →

Posted in Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Quick Insights, Systematic Reviews, Universal Interest | Tagged Acta Neuropathologica, Age and Ageing, Age-Related Pathologies, Ageing, Ageing and Dementia, Ageing Population, Amnestic MCI, Amnestic Mild Cognitive Impairment (a-MCI), Amnestic Mild Cognitive Impairment (aMCI), Banner Sun Health Research Institute, Biomarkers, Boston University, Civin Laboratory for Neuropathology: Banner Sun Health Research Institute, Cognitive Ageing, Cognitive Impairment, Columbia University, Columbia University Medical Center, Common Pathology Associated With Human Ageing, Department of Neuroscience: Mayo Clinic, Department of Pathology and Cell Biology: Columbia University Medical Center, Department of Pathology and Immunology: Washington University School of Medicine, Department of Physiology and Sanders-Brown Center on Aging: University of Kentucky, Departments of Pathology (Neuropathology) and Neurological Sciences: Rush University Medical Center, Division of Neuropathology: University of Pennsylvania, Emory University School of Medicine (Atlanta), Fishberg Department of Neuroscience and Friedman Brain Institute, Genetics and Pathology: Uppsala University, Harvard Medical School, Human Ageing Process, Icahn School of Medicine at Mount Sinai, Institute for Ageing and Health: Newcastle University, Institute of Clinical Neurobiology (Vienna), Kanazawa University Graduate School of Medical Sciences, Massachusetts General Hospital, Mayo Clinic, Mild Cognitive Impairment (MCI), Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Research, Neurofibrillary Tangles, Neurofibrillary Tangles (NFTs), Neuropathologic Disorders, Neuropathology, New York University School of Medicine, Newcastle University, NFT+/Aβ- Brains (Neurofibrillary Tangles Without Amyloid [Aβ] Plaques), Northwestern Cognitive Neurology and Alzheimer Disease Center: Northwestern University Feinberg School of Medicine, Northwestern University Feinberg School of Medicine, Oregon Health Sciences University, PART: Primary Age-Related Tauopathy, Primary Age Related Tauopathy (PART), Rush University Medical Center (US), Rush University Medical Center: Chicago, Sanders-Brown Center on Aging, Screening for Cognitive Impairment, Tau, Tau Pathology, Tau Protein, Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Tauopathy, Tokyo Metropolitan Geriatric Hospital, University of British Columbia, University of California, University of Iowa Hospitals and Clinics, University of Kentucky, University of Pennsylvania, University of Pennsylvania Perelman School of Medicine, University of Pittsburgh Medical Center, University of São Paulo, University of Texas Southwestern Medical School, University of Ulm, University of Washington, Uppsala University, VA Medical Center and Boston University School of Medicine, Washington University School of Medicine | Leave a comment

Recent Systematic Reviews and Meta-Analyses on Pharmacological Treatments

Posted on October 20, 2013 by Dementia and Elderly Care News

Some of the following articles are available freely, but a suitable Athens password, a journal subscription or one-off payment may be needed for access to the full-text of the other articles. The Bibliographic Citations Irwin, R.W. [and] Brinton, R.D. (2013). … Continue reading →

Posted in For Doctors (mostly), For Researchers (mostly), International, Management of Condition, Pharmacological Treatments, Systematic Reviews | Tagged Allopregnanolone, Alzheimer Neurobiology Center: Karolinska Institute, Alzheimer's Disease, Butyrylcholinesterase, Butyrylcholinesterase (BuChE), China, Cognitive Enhancers, Donepezil, EGb 761(®): Ginkgo Biloba Extract, France, Galantamine, Ginkgo Biloba Extract, Huperzine A, International Brain Research Foundation Inc.: USA, Karl-Landsteiner-Institut für Gedächtnis, Karolinska Institute, Lille Nord de France University, Marshall University Joan C. Edwards Medical School, Memantine, Memory Clinic: Sozialmedizinisches Zentrum Ost, Mirtazapine, Netherlands, Pharmacotherapy, Rivastigmine, Selected Systematic Reviews and Meta-Analyses, Selective Serotonin Reuptake Inhibitors (SSRIs), Sertraline, SNRI, SSRIs: Selective Serotonin Reuptake Inhibitors, Sweden, Systematic Reviews and Meta-Analyses, University of Amsterdam, University of British Columbia, University of Chinese Medicine: Beijing, University of Southern California, University of Sussex | Leave a comment

Tag Archives: University of British Columbia

Huntington’s Disease: a Blood Test “Speedometer”? (BBC News / Lancet Neurology)

Potential Relationship Between Vitamin A Deficiency and Alzheimer’s Disease Risk? (NHS Choices / Acta Neuropathologica)

International Variations in Cancer Referrals and Cancer Survival (BBC News / BMJ Open)

Recent Systematic Reviews and Meta-Analyses on Pharmacological Treatments

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites